HOME >> MEDICINE >> NEWS
Progesterone therapy could prevent thousands of preterm births

WHITE PLAINS, N.Y., JAN. 31, 2005 -- Nearly 10,000 preterm births could have been prevented in 2002 if all pregnant women at high risk for a premature baby and eligible for weekly injections of a derivative of the hormone progesterone had received them, according to a new study published in the February issue of Obstetrics & Gynecology.

The result would have been a reduction in the overall rate of preterm birth (before 37 completed weeks gestation) in the United States of about 2 percent -- from the 2002 rate of 12.1 percent to 11.8 percent -- say Joann R. Petrini, Ph.D., M.P.H., and colleagues from the March of Dimes, the Centers for Disease Control and Prevention, the National Institute of Child Health and Human Development (NICHD), Albert Einstein College of Medicine, Maimonides Medical Center in New York, and the New Jersey and Missouri State Departments of Health who participated in the analyses.

The hormone derivative is known as 17P, short for 17 alpha-hydroxyprogesterone caproate.

"Two percent would be a modest reduction in the preterm birth rate, but preventing 10,000 premature births would be very significant," said Dr. Petrini. "Prematurity is a serious problem that affects 1 in 8 babies in the U.S., and 17P offers promise in an area where there have been few successes. In addition, we need more research into the underlying causes of prematurity to help women with other risk factors."

Assumptions used to estimate the impact of 17P on recurrent preterm birth were based on criteria from the promising findings of the clinical trial reported by Paul J. Meis, M.D., et al. for the NICHD Maternal-Fetal Medicine Units (MFMU) Network in The New England Journal of Medicine on June 12, 2003. These study results led to the 2003 Committee Opinion issued by the American College of Obstetrician's and Gynecologists, published in the October 2003 issue of Obstetrics & Gynecology.

In the NICHD MFMU study
'"/>

Contact: Michele Kling
mkling@marchofdimes.com
914-997-4613
March of Dimes Birth Defects Foundation
31-Jan-2005


Page: 1 2

Related medicine news :

1. Study shows patch therapy may be as effective as oral medications
2. Novel therapy tested in mice could chase away cat allergies
3. Drug therapy may be comparable to invasive cardiac procedures for elderly patients with heart attack
4. Risk of cardiac death after radiotherapy for breast cancer has declined, study finds
5. Antiretroviral therapy may prevent excess risk of some cancers in people with HIV
6. Bevacizumab combined with chemotherapy prolongs survival for some patients with advanced lung cancer
7. Breakthrough in medical research: New chemotherapy gives hope to brain tumour patients
8. Two years after gene therapy treatments, severe angina patients showed prolonged clinical benefit
9. Combining PET and CT scans leads to more accurate radiation therapy for lung cancer patients
10. Cognitive behavioral therapy and medication is effective in the treatment of panic disorder
11. Study finds drug eluting stents as effective as vascular brachytherapy in preventing restenosis

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/27/2016)... Overland Park, KS (PRWEB) , ... June 27, 2016 , ... ... leader in retailers of Eyeglasses . , Millions of individuals in the United ... life, eyeglasses have become a way to both correct vision and make a fashion ...
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet supplements ... was developed to enhance the health of felines. The formula is all-natural and is ... herbs in the PawPaws Cat Kidney Support Supplement Soft Chews are Astragalus ...
(Date:6/25/2016)... TX (PRWEB) , ... June 25, 2016 , ... Austin ... of the American College of Mohs Surgery and to Dr. Russell Peckham for medical ... and highly effective treatment for skin cancer. The selective fellowship in Mohs Micrographic Surgery ...
(Date:6/25/2016)... ... 25, 2016 , ... As a lifelong Southern Californian, Dr. Omkar Marathe earned ... the David Geffen School of Medicine at UCLA. He trained in Internal Medicine at ... fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the opportunity ...
(Date:6/24/2016)... ... 24, 2016 , ... A recent article published June 14 on ... article goes on to state that individuals are now more comfortable seeking to undergo ... such as calf and cheek reduction. The Los Angeles area medical group, Beverly Hills ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... DUBLIN , June 27, 2016 Jazz ... the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act ... proposed acquisition of Celator Pharmaceuticals, Inc. ("Celator"; Nasdaq: ... 11:59 p.m. (Eastern Daylight Time). As previously ... entered into a definitive merger agreement under which Jazz ...
(Date:6/24/2016)... , June 24, 2016  Global Blood Therapeutics, ... company developing novel therapeutics for the treatment of ... announced the closing of its previously announced underwritten ... at the public offering price of $18.75 per ... were offered by GBT. GBT estimates net proceeds ...
(Date:6/24/2016)... BEIJING , June 24, 2016 Dehaier ... or the "Company"), which develops, markets and sells medical ... China , signed a strategic cooperation agreement with ... as "Hongyuan Supply Chain") on June 20, 2016, to ... Under the strategic cooperation agreement, Dehaier will leverage Hongyuan ...
Breaking Medicine Technology:
Cached News: